Abiopharma

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 2Q26

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Fast Track Entertainment Brings Dream Cruises’ 10th Anniversary Celebrity Strategy to Life with Chef Tommie Lee Onboard ‘Genting Dream’

National Healthcare Properties Provides Business Updates

Rocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

T3 Defense to Participate in the Noble Capital Markets Virtual Equity Conference on June 3-4

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Servier projette dacquérir lactivité dystrophie musculaire dEdgewise Therapeutics USA - Français USA - English USA - English

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH